Literature DB >> 1372390

Down-regulation of cystic fibrosis transmembrane conductance regulator gene expression by agents that modulate intracellular divalent cations.

J Bargon1, B C Trapnell, C S Chu, E R Rosenthal, K Yoshimura, W B Guggino, W Dalemans, A Pavirani, J P Lecocq, R G Crystal.   

Abstract

In cystic fibrosis (CF), epithelial cells are unable to normally up-regulate apical membrane Cl- secretion in response to agents which increase cyclic AMP, but they do increase Cl- secretion in response to increases in intracellular Ca2+. Since intracellular divalent cations regulate the expression of many genes, we hypothesized that mobilization of intracellular Ca2+ and/or other divalent cations might modulate not only Ca(2+)-dependent Cl- channels but also cystic fibrosis transmembrane conductance regulator (CFTR) gene expression. To evaluate this concept, HT-29 human colon carcinoma cells were cultured under various conditions designed to manipulate intracellular divalent cation concentrations and CFTR gene expression was quantified at the levels of transcription, mRNA accumulation, mRNA half-life, and protein. Exposure to the divalent cation ionophores A23187 and ionomycin (agents which increase intracellular divalent cation concentrations) caused dose- and time-dependent reductions of CFTR mRNA levels, which could be blocked by the use of Ca(2+)- and Mg(2+)-free media. Ionophore-induced CFTR gene modulation was also observed with T84 human colon carcinoma cells and freshly isolated normal human bronchial epithelial cells. Incubation of HT-29 cells with thapsigargin, an agent that releases Ca2+ from intracellular stores, or in medium containing increased extracellular concentrations of Ca2+ or Mg2+ also caused down-regulation of CFTR mRNA levels. Transcription run-on analysis showed that, parallel with the decrease in CFTR mRNA levels, A23187 reduced the rate of transcription of the CFTR gene, while CFTR mRNA transcript half-life was unaffected. Consistent with the down-regulation of CFTR gene expression, CFTR protein levels also decreased after exposure to A23187. Thus, despite the independence of Ca(2+)-dependent Cl- channels and cyclic AMP-dependent CFTR-related Cl- channels in epithelial cells, increases in intracellular divalent cation concentrations down-regulate the expression of the CFTR gene at the transcriptional level, with consequent decreases in CFTR mRNA and protein.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1372390      PMCID: PMC369631          DOI: 10.1128/mcb.12.4.1872-1878.1992

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  38 in total

1.  Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements.

Authors:  W Lee; P Mitchell; R Tjian
Journal:  Cell       Date:  1987-06-19       Impact factor: 41.582

2.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

3.  Cl- channels in CF: lack of activation by protein kinase C and cAMP-dependent protein kinase.

Authors:  T C Hwang; L Lu; P L Zeitlin; D C Gruenert; R Huganir; W B Guggino
Journal:  Science       Date:  1989-06-16       Impact factor: 47.728

Review 4.  Abnormal regulation of ion channels in cystic fibrosis epithelia.

Authors:  M J Welsh
Journal:  FASEB J       Date:  1990-07       Impact factor: 5.191

Review 5.  Studies and perspectives of protein kinase C.

Authors:  Y Nishizuka
Journal:  Science       Date:  1986-07-18       Impact factor: 47.728

6.  Separate Cl- conductances activated by cAMP and Ca2+ in Cl(-)-secreting epithelial cells.

Authors:  W H Cliff; R A Frizzell
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

7.  Isolation and characterization of full-length cDNA clones for human alpha-, beta-, and gamma-actin mRNAs: skeletal but not cytoplasmic actins have an amino-terminal cysteine that is subsequently removed.

Authors:  P Gunning; P Ponte; H Okayama; J Engel; H Blau; L Kedes
Journal:  Mol Cell Biol       Date:  1983-05       Impact factor: 4.272

8.  Identification of the cystic fibrosis gene: chromosome walking and jumping.

Authors:  J M Rommens; M C Iannuzzi; B Kerem; M L Drumm; G Melmer; M Dean; R Rozmahel; J L Cole; D Kennedy; N Hidaka
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

9.  Posttranscriptional stabilization of c-fms mRNA by a labile protein during human monocytic differentiation.

Authors:  B Weber; J Horiguchi; R Luebbers; M Sherman; D Kufe
Journal:  Mol Cell Biol       Date:  1989-02       Impact factor: 4.272

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  9 in total

1.  Cross-species characterization of the promoter region of the cystic fibrosis transmembrane conductance regulator gene reveals multiple levels of regulation.

Authors:  S Vuillaumier; I Dixmeras; H Messaï; C Lapouméroulie; D Lallemand; J Gekas; F F Chehab; C Perret; J Elion; E Denamur
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

2.  Basal expression of the cystic fibrosis transmembrane conductance regulator gene is dependent on protein kinase A activity.

Authors:  R A McDonald; R P Matthews; R L Idzerda; G S McKnight
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

3.  Localization of cystic fibrosis transmembrane conductance regulator mRNA in the human gastrointestinal tract by in situ hybridization.

Authors:  T V Strong; K Boehm; F S Collins
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

4.  Transfer of a constitutive viral promoter-cystic fibrosis transmembrane conductance regulator cDNA to human epithelial cells conveys resistance to down-regulation of cAMP-regulated Cl- secretion in the presence of inflammatory stimuli.

Authors:  N Kobayashi; E R Rosenthal; K Yoshimura; R G Crystal
Journal:  Nucleic Acids Res       Date:  1994-10-25       Impact factor: 16.971

5.  Function and regulation of TRPM7, as well as intracellular magnesium content, are altered in cells expressing ΔF508-CFTR and G551D-CFTR.

Authors:  F Huguet; M L Calvez; N Benz; S Le Hir; O Mignen; P Buscaglia; F D Horgen; C Férec; M Kerbiriou; P Trouvé
Journal:  Cell Mol Life Sci       Date:  2016-02-13       Impact factor: 9.207

6.  Calreticulin Ins5 and Del52 mutations impair unfolded protein and oxidative stress responses in K562 cells expressing CALR mutants.

Authors:  Simona Salati; Elena Genovese; Chiara Carretta; Roberta Zini; Niccolò Bartalucci; Zelia Prudente; Valentina Pennucci; Samantha Ruberti; Chiara Rossi; Sebastiano Rontauroli; Elena Enzo; Laura Calabresi; Manjola Balliu; Carmela Mannarelli; Elisa Bianchi; Paola Guglielmelli; Enrico Tagliafico; Alessandro M Vannucchi; Rossella Manfredini
Journal:  Sci Rep       Date:  2019-07-22       Impact factor: 4.379

7.  Evaluation of eluforsen, a novel RNA oligonucleotide for restoration of CFTR function in in vitro and murine models of p.Phe508del cystic fibrosis.

Authors:  Wouter Beumer; Jim Swildens; Teresinha Leal; Sabrina Noel; Herma Anthonijsz; Geert van der Horst; Hester Kuiperij-Boersma; Marko Potman; Charlotte van Putten; Patricia Biasutto; Gerard Platenburg; Hugo de Jonge; Noreen Henig; Tita Ritsema
Journal:  PLoS One       Date:  2019-06-28       Impact factor: 3.240

8.  An Adverse Outcome Pathway for Decreased Lung Function Focusing on Mechanisms of Impaired Mucociliary Clearance Following Inhalation Exposure.

Authors:  Karsta Luettich; Monita Sharma; Hasmik Yepiskoposyan; Damien Breheny; Frazer J Lowe
Journal:  Front Toxicol       Date:  2021-12-14

9.  Genistein-induced fluid accumulation in ovariectomised rats' uteri is associated with increased cystic fibrosis transmembrane regulator expression.

Authors:  Asma Chinigarzadeh; Normadiah M Kassim; Sekaran Muniandy; Naguib Salleh
Journal:  Clinics (Sao Paulo)       Date:  2014-02       Impact factor: 2.365

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.